CRISPR Revolution: The Future of Genetic Engineering Jennifer Doudna at CNBC Evolve 2021

Biochemist Jennifer Doudna is best known for her pioneering work in CRISPR gene editing, for which she was awarded the 2020 Nobel Prize in chemistry. She’s also a leading biotech entrepreneur, with several life science start-ups under her belt. In a rare interview, Doudna talks about the current work at her Innovative Genomics Institute at the University of California, Berkeley, where scientists are applying genome editing technology to diagnostics, drug discovery, agbiotech and even climate change.
Jennifer Doudna, UC Berkeley Biochemist and Nobel Prize winner, 2020
Interviewed by: Meg Tirrell, CNBC Senior Health & Science Reporter
Join us in July for our next CNBC Evolve Global Summit: bit.ly/3be78r2
More from the CNBC Events: www.CNBCEvents.com Subscribe to the
CNBC Events Marketing Newsletter here: bit.ly/3QlH7pO
Follow on Twitter: / cnbcevents
Follow on LinkedIn: / cnbcevents
#CNBC #Evolve #Genetic #engineering